Transcribed from a single exon antisense to the CDKN1A/p21 promoter region, PANDA is induced by p53 upon DNA damage and is often overexpressed in human cancers, granting its use as a diagnostic biomarker [178]. This evidence concerns the gene CDKN1A and cancer.